Journal article · 2019 · Open access

Lack of therapeutic efficacy of an antibody to α 4 β 7 in SIVmac251-infected rhesus macaques

Peter Abbink, Noe B. Mercado, Joseph P. Nkolola, Rebecca Peterson, Hubert Tuyishime, Katherine McMahan, Edward T. Moseley, Erica N. Borducchi, Abishek Chandrashekar, Esther Apraku Bondzie, Arshi Agarwal, Aaron J. Belli and 5 more

Science, 365(6457), 1029–1033 · Published 5 September 2019 · DOI 10.1126/science.aaw8562

Open PDFView at the publisherCite this paper

In brief

“Lack of therapeutic efficacy of an antibody to α 4 β 7 in SIVmac251-infected rhesus macaques” is a 2019 journal article by Peter Abbink and 16 co-authors, published in Science. OpenAlex counts 36 citations as of 19 November 2026. It is open access: the full text is free to read at Science.

Citations
36
Most cited in
2020 (10)
Field-weighted impact
2.78
References
17
Authors
17

Abstract

An antibody is not the antidote An HIV therapeutic that would give long-term remission without sustained antiretroviral therapy (ART) is a long-term goal. Byrareddy et al. [ Science 354 , 197 (2016)] reported that treating simian immunodeficiency virus (SIV)–positive macaques with an antibody against integrin α 4 β 7 during and after ART results in sustained virologic control after stopping all treatment. Three studies in this issue question the reproducibility of that result. Di Mascio et al. sequenced the virus used in the 2016 study and found that it was a variant with a stop codon in the nef gene rather than a wild-type virus. Abbink et al. used the same antibody for α 4 β 7 as before but tested control of a more commonly used pathogenic virus. Iwamato et al. used the same nef -stop virus as in the earlier paper but combined the antibody against the integrin with an antibody against the SIV envelope glycoprotein, which also blocks viral binding of the integrin. None of these three new studies found that treating with the antibody had any effect on virologic control after stopping ART treatment. Science , this issue p. 1025 , p. 1029 , p. 1033

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Abbink, P., Mercado, N. B., Nkolola, J. P., Peterson, R., Tuyishime, H., McMahan, K., Moseley, E. T., Borducchi, E. N., Chandrashekar, A., Bondzie, E. A., Agarwal, A., Belli, A. J., Reimann, K. A., Keele, B. F., Geleziunas, R., Lewis, M. G., & Barouch, D. H. (2019). Lack of therapeutic efficacy of an antibody to α 4 β 7 in SIVmac251-infected rhesus macaques. Science, 365(6457), 1029–1033. https://doi.org/10.1126/science.aaw8562

MLA 9

Abbink, Peter, et al. “Lack of therapeutic efficacy of an antibody to α 4 β 7 in SIVmac251-infected rhesus macaques.” Science, vol. 365, no. 6457, 2019, pp. 1029–1033. https://doi.org/10.1126/science.aaw8562.

Chicago

Abbink, Peter, Noe B. Mercado, Joseph P. Nkolola, Rebecca Peterson, Hubert Tuyishime, Katherine McMahan, Edward T. Moseley, et al. 2019. “Lack of therapeutic efficacy of an antibody to α 4 β 7 in SIVmac251-infected rhesus macaques.” Science 365 (6457): 1029–1033. https://doi.org/10.1126/science.aaw8562.

Harvard

Abbink, P. et al. (2019) ‘Lack of therapeutic efficacy of an antibody to α 4 β 7 in SIVmac251-infected rhesus macaques’, Science, 365(6457), pp. 1029–1033. doi:10.1126/science.aaw8562.

IEEE

P. Abbink et al., “Lack of therapeutic efficacy of an antibody to α 4 β 7 in SIVmac251-infected rhesus macaques,” Science, vol. 365, no. 6457, pp. 1029–1033, 2019, doi: 10.1126/science.aaw8562.

BibTeX

@article{abbink2019lack,
  title     = {{Lack of therapeutic efficacy of an antibody to α 4 β 7 in SIVmac251-infected rhesus macaques}},
  author    = {Abbink, Peter and Mercado, Noe B. and Nkolola, Joseph P. and Peterson, Rebecca and Tuyishime, Hubert and McMahan, Katherine and Moseley, Edward T. and Borducchi, Erica N. and Chandrashekar, Abishek and Bondzie, Esther Apraku and Agarwal, Arshi and Belli, Aaron J. and Reimann, Keith A. and Keele, Brandon F. and Geleziunas, Romas and Lewis, Mark G. and Barouch, Dan H.},
  journal   = {Science},
  year      = {2019},
  volume    = {365},
  number    = {6457},
  pages     = {1029--1033},
  doi       = {10.1126/science.aaw8562},
  url       = {https://doi.org/10.1126/science.aaw8562}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
201611
201933
20201010
20211010
202255
202311
202411
202544
202611

Its field-weighted citation impact is 2.78: it has been cited 2.78 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment

  • alpha4beta7 integrin
  • therapeutic antibodies
  • SIVmac251
  • rhesus monkeys
  • HIV cure
  • antiretroviral therapy
  • viral variants
  • integrin blockade

Work with this paper

Most-cited papers in Immunology and Microbiology

All highly cited Immunology and Microbiology papers

Questions about this paper

How do I cite this paper in APA style?

Abbink, P., Mercado, N. B., Nkolola, J. P., Peterson, R., Tuyishime, H., McMahan, K., Moseley, E. T., Borducchi, E. N., Chandrashekar, A., Bondzie, E. A., Agarwal, A., Belli, A. J., Reimann, K. A., Keele, B. F., Geleziunas, R., Lewis, M. G., & Barouch, D. H. (2019). Lack of therapeutic efficacy of an antibody to α 4 β 7 in SIVmac251-infected rhesus macaques. Science, 365(6457), 1029–1033. https://doi.org/10.1126/science.aaw8562

How many times has this paper been cited?

36 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Science: sign in and open the PDF from this page.

Who wrote this paper?

Peter Abbink, Noe B. Mercado, Joseph P. Nkolola, Rebecca Peterson, Hubert Tuyishime, Katherine McMahan, Edward T. Moseley, Erica N. Borducchi, Abishek Chandrashekar, Esther Apraku Bondzie, Arshi Agarwal, Aaron J. Belli and 5 more.

What is the DOI of this paper?

10.1126/science.aaw8562, permanently at https://doi.org/10.1126/science.aaw8562. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.